News for the Multiple Sclerosis Community

Bayhill withdraws IPO

Bayhill Therapeutics is working on an MS "vaccine." They recently withdrew their IPO, claiming the market is not favorable. No mention of what effect this would have on drug development.

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <a> <em> <i> <b> <strong> <cite> <strike> <code> <ul> <ol> <li> <dl> <dt> <dd> <blockquote>
  • Lines and paragraphs break automatically.
  • Site-relative links such as <a href="node/123"> will work correctly.
  • You can enter "<!--break-->" (without the quotes) to control where your post's teaser ends.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.